Implementation of Novel Affinity Ligand for Lentiviral Vector Purification

The use of viral vectors as therapeutic products for multiple applications such as vaccines, cancer treatment, or gene therapies, has been growing exponentially. Therefore, improved manufacturing processes are needed to cope with the high number of functional particles required for clinical trials a...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreira, Ana Sofia, Bezemer, Sandra, Faria, Tiago Q., Detmers, Frank, Hermans, Pim, Sierkstra, Laurens, Coroadinha, Ana Sofia, Peixoto, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966744/
https://www.ncbi.nlm.nih.gov/pubmed/36834764
http://dx.doi.org/10.3390/ijms24043354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966744/
https://www.ncbi.nlm.nih.gov/pubmed/36834764
http://dx.doi.org/10.3390/ijms24043354

Ejemplares similares